Anhui Fengyang Keyuan Pharmaceutical

Anhui Fengyang Keyuan Pharmaceutical is a specialized pharmaceutical manufacturer based in China, primarily focused on the production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. As a key subsidiary of Shandong Keyuan Pharmaceutical, the company operates large-scale, GMP-certified facilities in Fengyang, Anhui Province. It is recognized as one of the world's leading producers of metformin hydrochloride, a foundational treatment for type 2 diabetes. In addition to its metabolic portfolio, the company manufactures APIs for cardiovascular and peripheral vascular conditions, such as gliclazide and pentoxifylline. Fengyang Keyuan Pharmaceutical plays a vital role in the global drug supply chain, exporting high-quality chemical components to pharmaceutical companies across Asia, Europe, and the Americas.